Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

2.3K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.3K
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

53
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
53
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

1.8K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

1.4K
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The OxyCam: A novel hand-held vital microscope for quantitative measurement of microcirculatory perfusion and oxygenation.

Journal of intensive medicine·2026
Same author

Microcirculatory response and leukocyte activation in patients undergoing elective cardiac surgery with cardiopulmonary bypass.

Journal of intensive medicine·2026
Same author

What every intensivist should know about the endothelial glycocalyx.

Journal of critical care·2026
Same author

Diagnostic value of short-term longitudinal clinical and laboratory trajectories for gram-negative bacteremia in intensive care units patients.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026
Same author

Protective Effects of Pentoxifylline on Peripheral Microcirculatory Dysfunction and Renal Cortical Oxygen Deficiency in a Rat Model of LPS-Induced Sepsis.

Microcirculation (New York, N.Y. : 1994)·2026
Same author

Microcirculatory perfusion is improved with plasma, but not with crystalloids, in a rat polytraumatic shock model.

Transfusion·2026

Related Experiment Video

Updated: Apr 29, 2026

Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care
14:28

Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care

Published on: May 10, 2024

2.9K

The renal microcirculation in sepsis.

Bulent Ergin1, Aysegul Kapucu2, Cihan Demirci-Tansel3

  • 1Department of Translational Physiology, Academic Medical Center, Amsterdam, The Netherlands.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|May 23, 2014
PubMed
Summary
This summary is machine-generated.

Sepsis disrupts kidney oxygen balance, leading to acute kidney injury (AKI) through microcirculatory dysfunction. Restoring oxygen homeostasis and managing reactive species are key to treating septic AKI.

Keywords:
AKImicrocirculationnitric oxideoxygen radicalsoxygenation

More Related Videos

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
07:03

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury

Published on: February 15, 2022

1.3K
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.7K

Related Experiment Videos

Last Updated: Apr 29, 2026

Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care
14:28

Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care

Published on: May 10, 2024

2.9K
Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
07:03

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury

Published on: February 15, 2022

1.3K
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.7K

Area of Science:

  • Nephrology
  • Critical Care Medicine
  • Physiology

Background:

  • Septic acute kidney injury (AKI) pathophysiology remains incompletely understood despite known cellular mechanisms.
  • The renal microcirculation (MC) integrates multiple cellular failures contributing to AKI.
  • Kidneys are vulnerable to hypoxemic injury due to their structure, high energy demand, and borderline ischemic state.

Purpose of the Study:

  • To review the renal microcirculation's response to sepsis.
  • To discuss factors influencing renal MC (dys)function in sepsis.
  • To elucidate the role of renal MC dysfunction in the pathogenesis of renal failure during sepsis.

Main Methods:

  • Review of existing literature on renal microcirculation in sepsis.
  • Analysis of oxygen supply-demand balance in the kidney.
  • Examination of the interplay between oxygen handling, nitric oxide metabolism, and radical formation in septic AKI.

Main Results:

  • Sepsis disturbs the renal oxygen supply-demand balance, causing microcirculatory dysfunction.
  • Renal tissue oxygenation is heterogeneous, with MC deterioration being a key factor in septic AKI development.
  • Experimental therapies improving MC oxygenation show promise in restoring renal function.

Conclusions:

  • Integrative correction of homeostasis for oxygen and reactive species is crucial for kidney resuscitation in sepsis.
  • Further clinical studies are needed to validate experimental therapeutic approaches.
  • Development of MC-focused clinical biomarkers for AKI is essential for monitoring treatment efficacy.